Abstract. MicroRNAs (miRNAs) are a class of small, non-coding, endogenous RNAs that are important in tumor cell biological processes as they regulate gene expression. miR-195 has been demonstrated to be a tumor repressor in numerous types of human cancer. However, the mechanism by which miR-195 suppresses tumor development remains to be elucidated. The aim of this study was to investigate the effect of miR-195 on the biological functions of HepG2 hepatocellular carcinoma (HCC) cells and identify the association between miR-195 and Wnt3a in HCC. miR-195 mRNA expression levels in HCC tissues and cell lines were measured by reverse transcription polymerase chain reaction analysis. miR-195 function was measured with cell proliferation, cell cycle and apoptosis assays following transfection with miR-195 and anti-miR-195 sequences, and the respective controls. Luciferase reporter assay was used to determine whether Wnt3a was a target of miR-195. In addition, Wnt3a expression levels were determined in HCC cells using western blot analysis. The miR-195 expression levels were found to be reduced in HCC tissues and cell lines. miR-195 overexpression resulted in a reduction in cell proliferation. In addition, the overexpression of miR-195 in HCC cells induced G1 phase cell cycle arrest and promoted apoptosis. Furthermore, Wnt3a was demonstrated to be directly targeted by miR-195. These findings suggest that miR-195 is key in regulating cell proliferation, cell cycle and apoptosis through targeting Wnt3a. In addition, overexpression of miR-195 may be a potential therapeutic strategy in the treatment of HCC.
Introduction
Liver cancer is the fifth most common type of malignancy worldwide and the third most common cause of cancer-related mortality. As an aggressive disease with a poor outcome, liver cancer results in >600,000 fatalities per year (1, 2) . In total, ~90% of all primary liver cancer diagnoses are classified as hepatocellular carcinoma (HCC). Therefore, for the majority of the time, the terms liver cancer and HCC may be used interchangeably (3) . Studies have found that 70-90% HCC cases are caused by liver cirrhosis; the predominant risk factor for HCC worldwide is chronic hepatitis B virus infection (4) . HCC development occurs in multiple stages, which include genetic and epigenetic changes, the activation of oncogenes or the inactivation of tumor suppressor genes in cancer cells.
MicroRNAs (miRNAs) are a class of small, non-coding RNAs that regulate gene expression through targeted inhibition of transcription and translation. Recent studies have suggested that miRNAs are important in tumor cell biological processes, including cell proliferation, cell cycle, apoptosis, migration and invasion (5) (6) (7) . Furthermore, miRNAs have emerged as potential therapeutic agents for tumorigenesis due to the ability to downregulate multiple targets, not only in tumor progression and metastasis, but also in therapeutic resistance and tumor recurrence (8) . In HCC carcinogenesis and progression, certain miRNAs have been reported to be dysregulated, for example, miR-135, miR-21 and miR-17-92 are upregulated, and miR-122, miR-125, miR-375, miR-101 and miR-150 are downregulated (6, (9) (10) (11) (12) (13) (14) . Recently, miR-195 has been reported to exert vital functions in a number of types of cancer, including bladder, adrenocortical, breast and gastric cancer (15) (16) (17) (18) MTT cell proliferation and colony forming assays. A total of 5x10 3 HepG2 cells were seeded in 96-well culture dishes, and incubated for 24, 48 or 72 h at 37˚C in a humidified incubator with 5% CO 2 . Subsequently, 20 µl MTT was added to the cells and the cells were incubated for 4 h. The supernatant was removed and replaced with 150 µl dimethyl sulfoxide and the cells were then incubated at 37˚C in a humidified incubator with 5% CO 2 . The absorbance was measured at 490 nm using the FLUOstar OPTIMA (BMG Labtech, Ortenberg, Germany). To assess cell colony formation ability, 5x10
2 HepG2 cells transfected with either miR-195, miR-ctrl, anti-miR-195 or anti-ctrl were seeded in 6-well culture dishes. After 14 days incubation at 37˚C in a humidified incubator with 5% CO 2 , the cells were washed twice with phosphate-buffered saline (PBS) and stained with crystal violet solution. Images were obtained using Quantity One computer software (Bio-Rad). All assays were repeated three times.
Luciferase activity assay. A fragment of the 3' untranslated region (UTR) of Wnt3a was synthesized with SacI and XhoI restriction enzymes using the following primers: Wnt3a, 5'-CGCGAGTCTGCCAATATTGGCTGTGCTGC TCCAGGCAGGGTGGTGC-3'; and Wnt3a mutation, 5'-CGCGAGTCTGCCAATATTGGCTGAGGTGATCCAGG CAGGGTGGTGC-3'. HEK293 cells were obtained from the Key Laboratory of Environmentally and Genetically Associated Diseases at Xi'an Jiaotong University, Ministry of Education (Xi'an, China). A total of 1x10 4 HEK293 cells were seeded into each well of a 96-well plate, subsequent to pmirGLO-Wnt3a-3'UTR-wt or pmirGLO-Wnt3a-3'UTR-mut vector co-transfection with miR-195 or miR-ctrl for 24 h using Lipofectamine 2000 (Invitrogen Life Technologies). Firefly luciferase activity was measured at 24 h post-transfection using a Dual-Luciferase Reporter Assay system (Promega Corporation, Madison, WI, USA). The results were normalized with Renilla luciferase. Each reporter plasmid was transfected at least three times and each sample was assayed in triplicate.
Cell cycle analysis. HepG2 cells were transfected with miR-195, miR-ctrl, anti-miR-195 or anti-ctrl when the cells had grown to 70-90% confluence. The cells were then incubated at 37˚C for 48 h. Subsequently, the treated cells were collected and fixed in 70% ethanol at 4˚C overnight. The cells were then washed in PBS and incubated with 1 ml staining solution (20 µg/ml propidium iodide and 10 U/ml RNase A) for 30 min at room temperature.
The cell-cycle distributions were assayed by fluorescence-activated cell sorting using a flow cytometer (FACSort; Becton-Dickinson, Franklin Lakes, NJ, USA).
Apoptosis analysis. HepG2 cells were transfected with miR-195, miR-ctrl, anti-miR-195 or anti-ctrl when the cells had grown to 70-90% confluence. The cells were cultured at 37˚C for 48 h then harvested by trypsinization and centrifugation, and washed twice with PBS. The cells were then stained using an Annexin V/fluorescein isothiocyanate Apoptosis Detection kit (Invitrogen Life Technologies) according to the manufacturer's instructions. Cell apoptosis were examined using a flow cytometer (Becton-Dickinson).
Western blot analysis. Either miR-195 or anti-miR-195 was transfected into HepG2 cells using Lipofectamine 2000, with miR-ctrl and anti-ctrl serving as respective controls. Total proteins were isolated from the cells by radioimmunoprecipitation assay 48 h post-transfection. Protein concentrations were measured using a micro bicinchoninic acid protein assay kit (Pierce Biotechnology, Inc, Rockford, IL, USA). The proteins were resolved using a 10% SDS-PAGE gel, transferred onto the nitrocellulose membrane, blocked in 5% non-fat dry milk in Tris-buffered saline (pH 7.4) containing 0.05% Tween 20 (TBST) and incubated with rabbit polyclonal antibody against Wnt3a overnight at 4˚C (1:200; Beijing Biosynthesis Biotechnology Co., Ltd., Beijing, China). After washing three times with TBST, the membrane was incubated with a goat anti-rabbit IgG (1:5,000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) antibody for 2 h, then washed three times with TBST. GAPDH served as a control. Relative protein expression was measured on the Quantity One imaging software. All western blot analyses were performed three times.
Statistical analysis. All data are expressed as the mean ± standard deviation. Student's t-test was used for statistical analysis. P<0.05 and P<0.01 were considered to indicate statistically significant differences. All analyses were performed using SPSS 13.0 software (SPSS, Inc., Chicago, IL, USA). Fig. 2A and B) . In addition, miR-195-transfected cells exhibited lower colony formation ability compared with miR-ctrl-transfected cells. By contrast, anti-miR-195-transfected cells exhibited higher colony formation ability compared with anti-ctrl-transfected cells ( Fig. 2C and D) . These results indicate that miR-195 inhibited HepG2 cell proliferation and further suggests a tumor suppressive effect of miR-195 in HCC.
Results

miR-195 exhibits low-level expression in HCC tissues
miR-195 induces cell cycle arrest and apoptosis in HCC.
In 
Wnt3a is a direct target of miR-195.
To identify the molecular targets of miR-195, as miRNAs function mainly through posttranscriptional inhibition of target mRNAs via binding to the 3'UTR, an online miRNA target database TargetScan (http:// www.targetscan.org) was used to predict the target genes. Wnt3a has been indicated to be a potential target of miR-195 with a complementary 3'UTR binding site for the seed sequence of miR-195 (Fig. 4A) . Co-transfection of miR-195 along with Wnt3a wild-type 3'UTR resulted in a significant reduction in luciferase activity compared with that of the control (P<0.05). However, co-transfection with miR-195 along with the Wnt3a-mut did not reduce luciferase activity (Fig. 4B) . These results suggest that miR-195 directly targets Wnt3a. Additionally, western blot analysis was performed to measure the expression levels of Wnt3a protein in miR-195-transfected HCC cells and miR-195 transfection was found to reduce Wnt3a protein expression levels compared with miR-ctrl transfection. The expression levels of Wnt3a protein following transfection with anti-miR-195 or anti-ctrl were also determined (Fig. 4C) . The expression levels of Wnt3a protein were significantly increased in the cells transfected with anti-miR-195 compared with the cells treated with anti-miRNA-control after 48 h. The results revealed that the endogenously expressed Wnt3a was regulated by miR-195. These data demonstrate that Wnt3a is a direct target of miR-195.
In conclusion, these results suggest that overexpression of miR-195 inhibited HCC proliferation by repressing Wnt3a expression and that downregulation of miR-195 is important in the progression of HCC.
Discussion
Recent studies have shown that miRNAs exert wide effects through regulating the expression of a variety of genes in the majority of biological processes. Therefore, it is no surprise that miRNAs regulate the development of cancer. Investigating the role of individual miRNAs in cancer has generated great interest (20) ; the effects of differently expressed miRNAs may contribute to human carcinogenesis by regulating multivarious types of target gene expression (21) . Recently, studies have demonstrated that miR-195 suppresses human glioma cell proliferation by directly targeting the 3'UTRs of cyclin D1 and cyclin E1 (22) . miR-195 also exhibited an anti-apoptotic function in human colorectal cancer cells by targeting Bcl-2 (23) .
In recent years, a number of signaling pathways have been found to be associated with HCC (24) , including the AKT/mammalian target of rapamycin (25) mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (26), c-Jun N-terminal kinase (27) , nuclear factor-kappa B (28) and Wnt/β-catenin signaling pathways (29) . The Wnt/β-catenin signaling pathway is vital in tumorigenesis and the progression of numerous types of tumor (30, 31) . The Wnt signaling pathway was first associated with cancer when Wnt1a was identified as an oncogene in mouse breast cancer in 1982 (32) . Wnt/β-catenin signaling pathway-induced G1 phase progression through cyclin D1 and c-Myc transcriptional inductions has been considered to be a mediator between the cell cycle and Wnt signaling (33) (34) (35) (36) . Subsequent studies have revealed that cell proliferation, differentiation, apoptosis and other biological processes are affected by the Wnt signaling pathway (31) . Multiple factors in the Wnt signaling pathway, including Wnt, β-catenin, adenomatosis polyposis coli, Axin 
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and secreted frizzled-related protein 1, have been shown to be overexpressed in hepatocellular carcinoma cells (37, 38) . The β-catenin/T-cell factor heterodimer activates >60 target genes of the Wnt signaling pathway, such as c-myc, c-jun and cyclin D1. These unusual activated oncogenes induce rapid proliferation in liver cells and may result in HCC (36, 39, 40) . In the present study, miR-195 overexpression was identified to directly target Wnt3a-induced G1 phase cell cycle arrest and promote apoptosis. Furthermore, the reduction in cell proliferation was marked. The data suggest that miR-195 is a potential diagnostic marker and that Wnt3a may be a key target in gene treatment of HCC.
